In vitro activities of voriconazole, itraconazole, and terbinafine alone or in combination against Pythium insidiosum isolates from Brazil

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 2, 2008, Pages 767-769

  Argenta, Juliana S ^a   Santurio, Janio M ^b   Alves, Sydney H ^b   Pereira, Daniela I B ^a   Cavalheiro, Ayrton S ^b   Spanamberg, Andréia ^a   Ferreiro, Laerte ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE; TERBINAFINE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; BRAZIL; CHECKERBOARD MICRODILUTION METHOD; DILUTION; DRUG ACTIVITY; DRUG POTENTIATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PYTHIUM; PYTHIUM INSIDIOSUM; STRAIN IDENTIFICATION;

ANIMALS; ANTIFUNGAL AGENTS; BRAZIL; DOG DISEASES; DOGS; DRUG SYNERGISM; HORSE DISEASES; HORSES; INFECTION; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; NAPHTHALENES; PYRIMIDINES; PYTHIUM; SHEEP; SHEEP DISEASES; TRIAZOLES;

EID: 38649117592     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01075-07     Document Type: Article

References (18)

1. Bossche, H. V., M. Engelen, and F. Rochette. 2003. Antifungal agents of use in animal health: chemical, biochemical, and pharmacological aspects. J. Vet. Pharmacol. Ther. 26:5-29.
2. Cuenca-Estrella, M. 2004. Combinations of antifungal agents in therapy: what value are they? J. Antimicrob. Chemother. 54:854-869.
3. De Cock, A. W. A. M., L. Mendoza, A. A. Padhye, L. Ajello, and L. Kaufman. 1987. Pythium insidiosum sp. nov. the etiologic agent of pythiosis. J. Clin. Microbiol. 25:344-349.
4. Dykstra, M. J., N. J. H. Sharp, T. Olivry, A. Hillier, K. M. Murphy, L. Kaufman, G. A. Kunkle, and C. Pucheu-Haston. 1999. A description of cutaneous-subcutaneous pythiosis in fifteen dogs. Med. Mycol. 37:427-433.
5. Johnson, M. D., C. MacDougall, L. Ostrosky-Zeichner, J. R. Perfect, and J. H. Rex. 2004. Combination antifungal therapy. Antimicrob. Agents Chemother. 48:693-715.
6. Martinez, R. 2006. An update on the use of antifungal agents. J. Bras. Pneumol. 32:449-460.
7. McMeekin, D., and L. Mendoza. 2000. In vitro effect of streptomycin on clinical isolates of Pythium insidiosum. Mycologia 92:371-373.
8. Meletiadis, J., J. W. Mouton, J. L. Rodriguez-Tudela, J. F. G. M. Meis, and P. E. Verweij. 2000. In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans. Antimicrob. Agents Chemother. 44:470-472.
9. Moore-Landecker, E. 1996. Zoosporic fungi, p. 33-81. In Fundamentals of the fungi, 4th ed. Prentice Hall, Totowa, NJ.
10. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard. CLSI document M38-A. Clinical and Laboratory Standards Institute, Wayne, PA.
11. Pereira, D. I. B., J. M. Santurio, S. H. Alves, J. S. Argenta, L. Pötter, A. Spanamberg, and L. Ferreiro. 2007. Caspofungin in vitro and in vivo activity against Brazilian Pythium insidiosum strains isolated from animals. J. Antimicrob. Chemother. 60:1168-1171.
12. Pupaibool, J., A. Chindamporn, K. Patarakul, C. Suankratay, W. Sindhuphak, and W. Kulwichit. 2006. Human pythiosis. Emerg. Infect. Dis. 12:517-518.
13. Rodrigues, A., D. L. Graça, C. Fontoura, A. S. Cavalheiro, A. Henzel, S. E. Schwendler, S. H. Alves, and J. M. Santurio. 2006. Intestinal dog pythiosis in Brazil. J. Mycol. Med. 16:37-41.
14. Santurio, J. M., A. T. Leal, A. B. M. Leal, R. Festugatto, I. Lubeck, E. S. V. Sallis, M. V. Copetti, S. H. Alves, and L. Ferreiro. 2003. Three types of immunotherapies against pythiosis insidiosi developed and evaluated. Vaccine 21:2535-2540.
15. Schurko, A. M., L. Mendoza, C. A. Levesque, N. L. Desaulniers, A. W. de Cock, and G. R. Klaussen. 2003. A molecular phylogeny of Pythium insidiosum. Mycol. Res. 107:537-544.
16. Sekhon, A. S., A. A. Padhye, and A. K. Garg. 1992. In vitro sensitivity of Penicillium marneffei and Pythium insidiosum to various antifungal agents. Eur. J. Epidemiol. 8:427-432.
17. Shenep, J. L., B. K. English, L. Kaufman, T. A. Pearson, J. W. Thompson, R. A. Kaufman, G. Frisch, and M. G. Rinaldi. 1998. Successful medical therapy for deeply invasive facial infection due to Pythium insidiosum in a child. Clin. Infect. Dis. 27:1388-1393.
18. Triscott, J. A., D. Weedon, and E. Cabana. 1993. Human subcutaneous pythiosis. J. Cutan. Pathol. 20:267-271.